Showing results (2491-2500 of 4,401) with videos related to
Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|March 28, 2014
The HCV Revolution Did Not Happen OvernightAnn D KwongACS Medicinal Chemistry Letters|May 3, 2014
Antimalarial Drug Discovery: From Quinine to the Dream of EradicationAdam R RensloACS Medicinal Chemistry Letters|March 25, 2017
Prototypic 18F-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary CarcinomaMax Keller, Simone Maschauer, Albert Brennauer, et al.ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.ACS Medicinal Chemistry Letters|March 25, 2017
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan ParasitesWilliam Devine, Sarah M Thomas, Jessey Erath, et al.ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.ACS Medicinal Chemistry Letters|March 23, 2013
Improving the affinity of SL0101 for RSK using structure-based designRoman M Mrozowski, Rajender Vemula, Bulan Wu, et al.ACS Medicinal Chemistry Letters|September 16, 2014
Fragonomics: the -omics with real impactEdward R ZartlerPageof 441